Document is current
Any future updates will be listed below
-
Authors
Kumar, Avinash https://orcid.org/0000-0002-3009-0866
Saini, Shipra https://orcid.org/0000-0002-6689-4428
Das, Padmini https://orcid.org/0009-0001-2784-513X
Kumar, Manoj https://orcid.org/0000-0002-4781-2343
Sen, Manas Kamal https://orcid.org/0000-0002-2681-0381
Jha, Mona https://orcid.org/0009-0002-9169-2622
Deshawar, Shailly https://orcid.org/0009-0000-4854-6115
Garg, Tinu https://orcid.org/0009-0007-5271-1524
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 26 December 2025
First Online: 5 January 2026
Declarations
:
: The protocol was approved by Institutional Ethics committee, ESIC Medical College and Hospital Faridabad Haryana (INDIA) in accordance with the New Drugs and Clinical Trials Rules, 2019, ICMR Guidelines for Biomedical research on Human Subjects, ICH-GC guidelines which govern Good Clinical Practices and IEC/IRB operations, WMA Declaration of Helsinki, Brazil, Oct 2013 and 21 CFR part 56 and 21 CFR part 50. Written informed consent was secured from all participants after explaining the study objectives. Confidentiality of participant data was strictly maintained.
: All the authors give their consent to publish this manuscript in your esteemed journal.
: The authors declare no competing interests.
